Biocryst Pharmaceuticals (BCRX) Q4 2025 Earnings

3NovConfirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.13
-0.07
-0
0.06

Details

Expected EPS
0.0398
Actual EPS
0.06
Surprise EPS
0.02
Surprise Percent
+50.75%

Description

Biocryst Pharmaceuticals (BCRX) has reported earnings of 0.06 per share for Q4 2025.

0 Comments

Share your thoughts